Huang, Jing
Zhu, Honglin
Liu, Sijia
Li, Mengtao
Li, Yisha
Luo, Hui
Zuo, Xiaoxia
Funding for this research was provided by:
CAMS Innovation Fund for Medical Sciences (2021-I2M-1-005, 2021-I2M-1-005)
Article History
Received: 15 September 2023
Accepted: 10 January 2024
First Online: 17 January 2024
Declarations
:
: This study was approved by the medical ethics committee of Peking Union Medical College Hospital (PUMCH) and the ethics committee of the European League Against Rheumatism Scleroderma Trial and Research Group (EUSTAR).
: Not applicable.
: The authors declare no competing interests.